Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
Karen S. Anderson(Mayo Clinic in Arizona), M. Posner(Icahn School of Medicine at Mount Sinai)
Cited by 69
Related Papers
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
|Nature Communications|2019|194
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers
|Breast Cancer Research and Treatment|2022|23